0000950170-24-024224.txt : 20240301 0000950170-24-024224.hdr.sgml : 20240301 20240301195405 ACCESSION NUMBER: 0000950170-24-024224 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240301 DATE AS OF CHANGE: 20240301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CAMPBELL CHAD A CENTRAL INDEX KEY: 0001862053 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15925 FILM NUMBER: 24712432 MAIL ADDRESS: STREET 1: 4000 MERIDIAN BLVD CITY: FRANKLIN STATE: TN ZIP: 37067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC CENTRAL INDEX KEY: 0001108109 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 133893191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4000 MERIDIAN BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 615-465-7000 MAIL ADDRESS: STREET 1: 4000 MERIDIAN BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 FORMER COMPANY: FORMER CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC/ DATE OF NAME CHANGE: 20000229 4 1 ownership.xml 4 X0508 4 2024-03-01 0001108109 COMMUNITY HEALTH SYSTEMS INC CYH 0001862053 CAMPBELL CHAD A 4000 MERIDIAN BOULEVARD FRANKLIN TN 37067 false true false false Regional President false Common Stock 2024-03-01 4 M false 15000 0 A 104718 D Common Stock 2024-03-01 4 A false 25000 0 A 129718 D Common Stock 2024-03-01 4 F false 14431 2.87 D 115287 D Performance Based Restricted 0 2024-03-01 4 M false 15000 0 D Common Stock 15000 0 D Performance Based Restricted 0 2024-03-01 4 A false 50000 0 A Common Stock 50000 50000 D Stock Options (Right to Buy) 2.87 2024-03-01 4 A false 25000 0 A 2025-03-01 2034-02-28 Common Stock 25000 25000 D Performance Based Restricted 0 Common Stock 50000 50000 D Performance Based Restricted 0 Common Stock 50000 50000 D Stock Options (Right to Buy) 4.93 2021-03-01 2030-02-28 Common Stock 15000 15000 D Stock Options (Right to Buy) 8.81 2022-03-01 2031-02-28 Common Stock 15000 15000 D Stock Options (Right to Buy) 10.18 2023-03-01 2032-02-29 Common Stock 25000 25000 D Stock Options (Right to Buy) 6.15 2024-03-01 2033-02-28 Common Stock 25000 25000 D The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period. Christopher G. Cobb, Attorney in Fact for Chad A. Campbell 2024-03-01 EX-24.TXT 2 cyh-ex24_txt.htm EX-24.TXT EX-24.txt

POWER OF ATTORNEY

Know all by these presents, that the undersigned

officer and/or director (herein, the Filer) of

COMMUNITY HEALTH SYSTEMS, INC., (the Company)

hereby constitutes and appoints each of

JUSTIN D. PITT, KEVIN J. HAMMONS, CHRISTOPHER

G. COBB and CAROL R. CLIFTON, signing singly,

the Filer's true and lawful attorney-in-fact to:

1.
execute for and on behalf of the Filer, a

FORM ID (or any such form as may be adopted)

for the purpose of obtaining on behalf of

Filer, a CIK, CCC and other filing codes and

related items from the Securities and Exchange

Commission (the SEC) as necessary to permit

each such Filer to make filings on the SECs

Electronic Data Gathering, Analysis and

Retrieval system, and to perform all acts

necessary in order to obtain such codes and

related items as he or she shall deem

appropriate; 2. execute for and on behalf

of the Filer, in the Filers capacity as an

officer and/or director of the Company, Forms

3, 4, and 5 in accordance with Section 16(a)

of the Securities Exchange Act of 1934 and the

rules thereunder; 3. execute for and on behalf

of the Filer, in the Filer's capacity as an

officer and/or director of the Company one or

more notices on Form 144 relating to any orders

or instructions to sell securities of the Company

in accordance with Rule 144 under the Securities

Act of 1933 and the rules thereunder; 4. do and

perform any and all acts for and on behalf of

the Filer which may be necessary or desirable

to complete and execute any such Form 3, 4, 5,

or 144 complete and execute any amendment or

amendments thereto, and timely file such form

with the United States Securities and Exchange

Commission and any stock exchange or similar

authority; and 5. take any other action of any

type whatsoever in connection with the foregoing

which, in the opinion of such attorney-in-fact,

may be of benefit to, in the best interest of,

or legally required by the Filer in his or her

capacity as an officer and/or director of the

Company, it being understood that the documents

executed by such attorney-in-fact on behalf of

the Filer pursuant to this Power of Attorney

shall be in such form and shall contain such

terms and conditions as such attorney-in-fact

may approve in such attorney-in-fact's

discretion. The Filer hereby grants to each such

attorney-in-fact full power and authority to do

and perform any and every act and thing whatsoever

requisite, necessary, or proper to be done in the

exercise of any of the rights and powers herein

granted, as fully to all intents and purposes as

the undersigned might or could do if personally

present, with full power of substitution or

revocation, hereby ratifying and confirming all

that such attorney-in-fact, or such

attorney-in-fact's substitute or substitutes,

shall lawfully do or cause to be done by virtue

of this power of attorney and the rights and powers

herein granted. The Filer acknowledges that the

foregoing attorneys-in-fact, in serving in such

capacity at the request of the Filer, are not

assuming, nor is the Company assuming, any of the

Filers responsibilities to comply with Section 16

of the Securities Exchange Act of 1934 or Rule 144

of the Securities Act of 1933. This Power of Attorney

shall remain in full force and effect until the

Filer is no longer required to file Forms

3, 4, 5, or 144 with respect to the Filer's holdings

of and transactions in securities issued by the

Company, unless earlier revoked by the Filer in

a signed writing delivered to the foregoing

attorneys-in-fact.

IN WITNESS WHEREOF, the Filer has caused this Power

of Attorney to be executed as of this 15th day of

September, 2023.

/s/ Chad A. Campbell

Chad A. Campbell